Leaders in Complement
At Apellis, we are committed to developing transformative therapies for people living with a broad range of debilitating diseases by controlling complement, part of the body’s immune system.

Our work is rooted centrally at C3, which is the only target in the complement cascade that addresses all three pathways that can drive disease. Targeting C3 has broad platform potential to treat many diseases where patients have few or no treatment options available.

Bold at Our Core

Our company is formed by people who care, are fearless in the face of a challenge, love the work they do, are resourceful, and continually pursue the highest level of scientific integrity. These values guide every decision that we make as we work toward our vision of being a compassionate organization known for its revolutionary science and contributions to humankind.
 

• We Care: We are dedicated to improving the lives of patients, their families and our employees.
• We are Fearless: We take risks and push ourselves to be more productive and innovative.
• We Love What We Do: We are passionate about our work, our purpose and the positive impact we can make.
• We are Resourceful: We challenge ourselves to do things in the most agile and efficient way.
• We are Compliment:  We continually pursue the highest level of scientific integrity, inclusion, curiosity and collaboration.

Our Culture

At Apellis, we act with respect, transparency, and integrity and are driven by the ability to make a meaningful impact in the patients we serve. We come from a diverse background and believe that each Apellucian’s unique skills and expertise will help us get closer to achieving our vision of becoming a leader in the biotech industry that is known for its compassion, revolutionary science, and contributions to humankind around the world.

Our culture centers around a profound sense of purpose: we care, we are fearless, we love what we do, we are resourceful, and we are experts in complement.  In other words, we care fiercely and ignite progress.